Login with your work email address to view charts. No credit card required.
| Art Unit: | 1614 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 514 — Drug, bio-affecting and body treating compositions 504 — Plant protecting and regulating compositions 536 — Organic compounds -- part of the class 532-570 series 385 — Optical waveguides 252 — Compositions 423 — Chemistry of inorganic compounds |
| Phone: | (571) 272-9925 |
| Email: | ali.soroush@uspto.gov |
| Location: | VA 22314 |
| Title: | Supervisory Patent Examiner |
| Service: | 20 years |
| Grade: | GS-15 |
| 3-Year Grant rate: | 43% over 285 cases |
|---|---|
| Difficulty: | Very Hard |
| Difficulty Percentile: | 85th
|
With Examiner Soroush (SPE), you have a 43% chance of getting an issued patent by 3 years after the first office action. Examiner Soroush (SPE) is a very hard examiner and in the 85th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Soroush (SPE), where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Soroush (SPE)'s grant rate is lower than that of Art Unit 1614 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Soroush (SPE) | 2.0 |
| Art Unit 1614 | 2.1 |
Examiner Soroush (SPE) has granted 83 of 212 cases without any applicant-requested interviews for a grant rate of 39%.
Examiner Soroush (SPE) has granted 39 of 73 cases with at least one applicant-requested interview for a grant rate of 53%.
With Examiner Soroush (SPE), conducting an interview increases your chance of getting a patent granted by 36%.
| Number | Title | OA Rejections | Status | IFW |
|---|---|---|---|---|
| 17922865 | New Compositions And Methods Of Treating Covid-19 Disease | Rejection information available with a Premium Stats subscription. See our pricing. | Abandoned | View |
| 16975257 | Proton Pump Inhibitors And Methods Of Use In Chemoradiation-Induced Tissue Inflammation And Scarring | Abandoned | View | |
| 18034869 | Novel Fxr Agonist Having Pyrazine Structure, And Preparation Method And Use | Patented | View | |
| 17907640 | Treatment Of Hyperinflammatory Syndrome | Patented | View | |
| 17506269 | Composition Comprising Antimicrobial Metal Ions And A Quaternary Cationic Surfactant | Abandoned | View | |
| 16620382 | Skin Care Formulations And Skin Cancer Treatment | Patented | View | |
| 18583696 | Methods And Polymer Compositions For Treating Retinal Detachment And Other Ocular Disorders | Abandoned | View | |
| 16965077 | Hydrophilic/hydrophobic Pharmaceutical Composition And Method Of Its Production And Use | Patented | View | |
| 16956237 | Bca Control Of Stb | Patented | View | |
| 17331543 | Hyaluronic Acid-Based Gels Including Lidocaine | Abandoned | View | |
| 18672876 | Trace Element Compositions, Methods Of Making And Use | Patented | View | |
| 16398147 | Concentrated Liquid Compositions Of Urease Inhibitors For Nitrogen Sources | Patented | View | |
| 16325169 | Magnetically Immobilized Biocidal Enzymes And Biocidal Chemicals | Patented | View | |
| 17969739 | High Glycerol Composition Comprising Blends Of Alkyl Isethionate And Alkyl Taurate | Abandoned | View | |
| 17706224 | Nanoparticle Compositions, Formulations Thereof, And Uses Therefor | Abandoned | View | |
| 16637182 | Water Vapor Suppression Material And Production Method Therefor | Abandoned | View | |
| 17252532 | Hydrogel Composition Comprising A Crosslinked Polymer | Patented | View | |
| 18281326 | Use Of Application Mode Of Trichoderma Harzianum (T. Harzianum) In Growth And Induced Resistance Of Nicotiana Tabacum (N. Tabacum) | Patented | View | |
| 17630512 | Application Of Tannic Acid In Preparation Of Medicament Against Respiratory Viruses | Patented | View | |
| 18458057 | Cis-Platinum Cross-Linked Protein Hydrogel And Preparation Method Thereof | Patented | View | |
| 17181781 | Bismuth-Thiols As Antiseptics For Biomedical Uses, Including Treatment Of Bacterial Biofilms And Other Uses | Abandoned | View | |
| 16899699 | Methods And Compositions For Improving Outcomes Of Cancer Patients | Abandoned | View | |
| 16664698 | Methods Of Treatment With Mixed Metal Compound | Abandoned | View | |
| 18238817 | Method Of Treating Parkinson's And Other Neurodegenerative Diseases | Patented | View | |
| 17488826 | Monomethylfumarate Prodrug Compositions | Abandoned | View | |
| 17123307 | System And Method For Antibiotic Delivery Using Single-Walled Carbon Nanotubes | Abandoned | View | |
| 16330682 | Topical Trpv1 Antagonists And Methods And Compositions Thereof | Abandoned | View | |
| 17741729 | Methods Of Treating Inflamation And/or Pain | Patented | View | |
| 17964450 | Stable Microcapsule Compositions | Patented | View | |
| 16451967 | Encapsulation Of Metal Oxide Nanomaterials For Controlled Release And Targeted Delivery | Abandoned | View | |
| 18124391 | Trace Element Compositions, Methods Of Making And Use | Patented | View | |
| 17673543 | Methods Of Treatment Of Hla-B27 Related Inflammatory Diseases And Compositions Related To Same | Patented | View | |
| 16849057 | Composition For Ameliorating Post-Cerebral Stroke Sequela | Abandoned | View | |
| 18155264 | Preparation Method Of Eucalyptol Emulsion And Application Thereof In Biopesticides | Patented | View | |
| 18482612 | Trace Element Compositions, Methods Of Making And Use | Patented | View | |
| 17214377 | Method Of Treating Alzheimer's Disease | Abandoned | View | |
| 16873181 | Ast-120 For Non-Systemic Newborn And Pediatric Hyperammonemia Therapy | Abandoned | View | |
| 17646207 | Prevention Of Boar Taint And Aggression | Abandoned | View | |
| 17024268 | Wet-Packed Soft Hydrogel Ocular Inserts | Patented | View | |
| 17332814 | Ophthalmic Formulations Of Cetirizine And Methods Of Use | Patented | View | |
| 17122072 | Vasoprotective And Cardioprotective Antidiabetic Therapy | Patented | View | |
| 16620674 | High Glycerol Composition Comprising Blends Of Alkyl Isethionate And Alkyl Taurate | Abandoned | View | |
| 18210915 | Foliar Spraying Of Curcuma Longa Plants With Chlorella Vulgaris Algae Aquatic Extract Improved Growth And Curcuminoid Accumulation | Patented | View | |
| 17503751 | Method For Preparing An Eruca Sativa Extract And Use For Shaving | Patented | View | |
| 17050135 | Topical Pharmaceutical Composition For Treatment Of Anal Fissures And Hemorrhoids | Patented | View | |
| 16962948 | Compositions For The Treatment Of A Disease Of The Urinary Tract And Treatment Of A Disease Involving The Intracellular Delivery Of The Particle Or A Medicament Contained Therein | Abandoned | View | |
| 16449431 | Method And Formulation For Treatment Of Wounds By New Tissue Regeneration With Reduced Trauma And Scar Tissue Formation | Abandoned | View | |
| 15935707 | Extracellular Matrix Compositions With Bactericidal Or Bacteriostatic Characteristics Useful For Protecting And Treating Patients With Bacterial Infections | Abandoned | View | |
| 16740007 | Trans-Mucosal Delivery System For Testosterone | Patented | View | |
| 16980377 | Transdermal And/or Dermal Delivery Of Lipophilic Active Agents | Abandoned | View |
Subscribe to Premium Examiner Statistics for unlimited access for your law firm.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.